Noul Co.,Ltd. (KOSDAQ:376930)

Market Cap	93.50B -18.4%
Revenue (ttm)	3.91B +72.6%
Net Income	-20.20B
EPS	-546.77
Shares Out	51.29M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	425,419
Average Volume	699,171
Open	1,851.00
Previous Close	1,874.00
Day's Range	1,820.00 - 1,865.00
52-Week Range	1,686.00 - 4,190.00
Beta	-0.54
RSI	42.60
Earnings Date	Mar 20, 2026

About Noul Co.,Ltd.

Noul Co.,Ltd. engages in the in-vitro diagnosis and remote diagnosis business worldwide. It offers miLab, an AI-based blood diagnostic medical device that automates sample preparation, imaging, and analysis. The company also provides malaria diagnostics, blood cell morphology analysis, cancer morphology, immunohistochemistry services, and digital cervical cell analysis solution. Noul Co.,Ltd. was incorporated in 2015 and is headquartered in Yongin-si, South Korea.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2015
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 376930

Financial Performance

In 2024, Noul Co.,Ltd.'s revenue was 1.60 billion, a decrease of -41.42% compared to the previous year's 2.73 billion. Losses were -22.47 billion, 37.7% more than in 2023.